Crista Galli Ventures
VC Fund
Copenhagen, Denmark
Crista Galli Ventures is a venture capital firm that invests in healthtech at Seed and Series A stages.
- Total investments:
- 37
- Last investment:
- Lead investor:
- 3%
Last updated:
For AI agents: llms.txt
Industries Crista Galli Ventures invests in
Stages Crista Galli Ventures invests in
Countries Crista Galli Ventures invests in
Round sizes
Round size
- Seed
- $960k–$9.2M
- Pre-Seed
- $623k–$2.5M
- Series A
- $5.7M–$14M
Investment Focus
Industry
- Health Care 20 (54%)
- Medical 7 (19%)
- Wellness 7 (19%)
- Artificial Intelligence 7 (19%)
- Biotechnology 6 (16%)
Stage
- Seed 15 (41%)
- Pre-Seed 8 (22%)
- Series A 4 (11%)
- Venture - Series Unknown 3 (8%)
- Series B 2 (5%)
Country
- United Kingdom 10 (27%)
- United States 7 (19%)
- Sweden 2 (5%)
- Denmark 2 (5%)
- Germany 2 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Whether you're a patient recovering from knee surgery or a desk worker starting to feel an ache in your back, the first step to getting you back to your best is getting an accurate measurement of your issue. Vitrue's products accurately and objectively measure musculoskeletal issues from the workplace to the clinic. VIDA is atech-driven, fully managed service to reduce musculoskeletal problems like back and neck pain in desk workers. All while making companies DSE compliant for remote, office and hybrid teams. By assessing the quality of desk workers’ workspaces through cutting-edge AI, VIDA is a modern and scalable solution with impactful benefits. 65% of employees are living with MSK issues like back or neck pain. In most cases, this is entirely preventable. With VIDA, you can empower your team to improve their workspace by giving them the knowledge they need to reduce pain and improve their quality of life. Vitrue EVVA uses depth sensors to perform clinical grade assessments of patients and is used in orthopaedics, elite sport injury prevention and preventative health screening. We provide computer vision based biomechanics measurement technology to assess your clients’ performance of gold standard functional movements pre and post treatment and throughout rehabilitation. We provide data to both clinicians and patients to ensure issues are detected early, optimal treatment can be designed and patients are informed and engaged throughout their experience.Our mission is to provide a new foundation for musculoskeletal healthcare and reduce MSK pain in millions of people. | $4M / Seed / Feb 29, 2024 | ||
| Hey, we're Jude. A healthcare start-up on a mission is to bring bladder care into the mainstream. | $4.5M / Seed / Sep 03, 2023 | ||
| Collective Minds® is the new radiology workspace. A cloud-based service for collaboration, consultation and access to new digital tools and expertise. We are building the largest global network of collective and artificial intelligence, with humans and machines. | $7.7M / Aug 28, 2023 | ||
| Gleamer develops an AI-powered software to enhance radiologists’ productivity. | $29.5M / Series B / Jun 28, 2023 | ||
| Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London. | $14M / Series A / May 15, 2023 | ||
| 52 North Health aims to improve healthcare with a medical device that uses artificial intelligence (AI) to determine the risk of neutropenic sepsis for patients undergoing chemotherapy. | $120.5K / Seed / Feb 07, 2023 | ||
| Subtle Medical is a healthcare technology company that provides AI-powered medical imaging. Its products, SubtlePET and SubtleMR, are FDA Cleared and CE Marked AI product that enhances images in PET and MR exams aimed for faster & safer workflow.The company's SubtleGAD technology is also awarded by RSNA and a $1.6M NIH SBIR Grant tofacilitate the adoption using AI to make imaging exams safer. They provide a vendor-agnostic AI infrastructure powering its products and providing service and analytics to clinical imaging providers.Subtle Medical's goal is to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose. | $25M / Series B / Nov 17, 2022 | ||
| Sapien Health is on a mission to help people everywhere on their journey to a healthier life. Our Digital Clinic for Surgery helps people prepare their mind and body for surgery through sustainable lifestyle changes. It’s the only digital care platform for surgery that provides people with expert human support and personalised health managementstrategies to optimise preparation and accelerate recovery. | $2.6M / Seed / Nov 15, 2022 | ||
| Surgery Hero is the world’s first digital prehabilitation clinic - helping people prepare for and recover from surgery at home. Optimising body and mind prior to surgery lowers the risk of surgical complications and accelerates recovery. | $2.4M / Seed / Nov 15, 2022 | ||
| Powered by genomics, skin microbiome science, and machine learning, Parallel is an end-to-end next-generation skin health company providing derm telehealth, cutting-edge skin microbiome diagnostics, precision microbiome skincare, and personalized Rx | $1.2M / Pre-Seed / Jul 31, 2022 | ||
| See all 37 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Crista Galli Ventures invest in?
Crista Galli Ventures invests primarily in Health Care, Medical and Wellness startups, most often at Seed and Pre-Seed stage. Most of the 37 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Crista Galli Ventures's check size?
Crista Galli Ventures typically joins rounds of $960k–$9.2M at Seed, $623k–$2.5M at Pre-Seed and $5.7M–$14M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Crista Galli Ventures participates in.
When did Crista Galli Ventures last invest?
The most recent investment recorded for Crista Galli Ventures closed in Feb 2024. Shizune tracks 37 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
